Concepedia

Megan M. Cleary

MM

Statistics

Publications

8

Citations

153

H-Index

8

Active since

2016

Affiliations

Children's Cancer Therapy Development Institute(Current)

Oregon Health & Science University

Automatic Data Processing (United States)

The University of Texas at San Antonio Health Science Center

National Institutes of Health

Megan M. Cleary is an author at Children's Cancer Therapy Development Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

2016–2023

8

Publications

8

Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia

Nameeta P. Richard, Raffaella Pippa, Megan M. Cleary et al. · Oncotarget · 2016 · 32 citations · Full text

, , +17

Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema

David W. Hutton, Adam R. Glassman, Danni Liu et al. · JAMA Ophthalmology · 2023 · 24 citations · Full text

, , +10

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

Narendra Bharathy, Matthew N. Svalina, Teagan P. Settelmeyer et al. · Oncotarget · 2017 · 19 citations · Full text

, , +13

Defining the Extracellular Matrix of Rhabdomyosarcoma

Xiaolei Lian, J. Steffan Bond, Narendra Bharathy et al. · Frontiers in Oncology · 2021 · 18 citations · Full text

, , +16

EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma

Matthew E. Randolph, Megan M. Cleary, Zia Bajwa et al. · PLoS ONE · 2017 · 17 citations · Full text

, , +17

1–5 of 8